Biểu đồ giá cổ phiếu BLRX
BLRX Dự đoán giá cổ phiếu
BioLineRx Ltd.
$3.1
-7.46%
$-0.25
Khi đóng cửa: May 07, 16:00:00 GMT-4
$3.1
0%
$0
Phiên sau giờ: May 07, 20:00:00 GMT-4
Quay lại
BioLineRx Ltd. (BLRX) Dự đoán giá cổ phiếu
Thống kê chính
Giá đóng cửa trước
$3.35
Giá mở cửa
$3.29
Phạm vi ngày
$3.1 - $3.33
Phạm vi 52 tuần
$2.15 - $7.77
Khối lượng
13.5K
Khối lượng trung bình
18.3K
Tỷ suất cổ tức
--
EPS (TTM)
0.00
Vốn hóa thị trường
$13.4M
BioLineRx Ltd. là gì?
BioLineRx Ltd. is a clinical stage biopharmaceutical company, which engages in the research and development of treatments that focus on cancer. The company is headquartered in Modiin, Central(Hamerkaz) and currently employs 24 full-time employees. The company went IPO on 2007-01-30. The firm is commited into in-license novel compounds, develop them through clinical stages, and then partner with pharmaceutical companies for further clinical development andcommercialization. The firm is commited into two projects: Motixafortide (BL-8040), which is a cancer therapy platform , and AGI-134, an immunotherapy treatment.
